SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-118163
Filing Date
2020-10-26
Accepted
2020-10-26 16:04:26
Documents
9
Period of Report
2020-10-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2033321d3_8k.htm 8-K 30197
2 EXHIBIT 1.1 tm2033321d3_ex1-1.htm EX-1.1 292919
3 EXHIBIT 4.1 tm2033321d3_ex4-1.htm EX-4.1 63980
4 EXHIBIT 5.1 tm2033321d3_ex5-1.htm EX-5.1 11868
5 EXHIBIT 5.2 tm2033321d3_ex5-2.htm EX-5.2 12695
6 EXHIBIT 99.1 tm2033321d3_ex99-1.htm EX-99.1 8596
7 GRAPHIC tm2033321d3_ex5-1image001.jpg GRAPHIC 2871
8 GRAPHIC tm2033321d3_ex5-1image002.jpg GRAPHIC 1270
9 GRAPHIC tm2033321d3_ex5-2img01.jpg GRAPHIC 7292
  Complete submission text file 0001104659-20-118163.txt   437711
Mailing Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6
Business Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38899 | Film No.: 201260774
SIC: 2834 Pharmaceutical Preparations